Please login to the form below

Not currently logged in
Email:
Password:

Aptiv Solutions promotes Dr Phil Birch and Carolyn Belcher

The US contract research organisation said the appointments fill key strategic posts

US contract research organisation (CRO) Aptiv Solutions has made changes to its executive team, promoting Dr Phil Birch and Carolyn Belcher.

Dr Birch, previously senior vice president of global regulatory at the CRO, will step up to the newly-created position of senior vice president and corporate brand manager for adaptive clinical trials.

In his new role he will focus on brand development, market education and developing strategic partnerships across the business. Prior to joining the company he spent five years at Fulcrum Pharma as general manager, Europe.

Aptiv's other executive change sees former Novartis employee Carolyn Belcher replace Dr Birch as senior director and global head of the Aptiv Solutions Regulatory Business Unit.

Her other previous roles include a stint as a clincial research scientist in the UK's NHS as well as senior director and global head of regulatory affairs and strategic drug development services at SRA Global Clinical Development.

Pat Donnelly, Aptiv's chairman and CEO, said: “This past year, we have seen a dramatic increase in sponsor interest in pursuing adaptive design clinical trials and as an organisation we are aligning strong leadership and expertise to focus internal resources to help our clients develop, design and execute best-in-class adaptive clinical programmes.”

5th December 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics